Showing results (371-380 of 554) with videos related to
Sort By:
Pageof 56
The Journal of Antimicrobial Chemotherapy|January 22, 2020
Genomic dynamics of species and mobile genetic elements in a prolonged blaIMP-4-associated carbapenemase outbreak in an Australian hospitalA Kizny Gordon, H T T Phan, S I Lipworth, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group studyJoseph I Clark, Jessica Mehrabi, Jeffrey A Sosman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinomaMichael B Atkins, Manuel Hidalgo, Walter M Stadler, et al.Journal for Immunotherapy of Cancer|May 3, 2023
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designsTian Zhang, Patrick M Forde, Ryan J Sullivan, et al.Scientific Reports|April 27, 2019
Warmer waters masculinize wild populations of a fish with temperature-dependent sex determinationJ L Honeycutt, C A Deck, S C Miller, et al.The Oncologist|September 10, 2008
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinibMario E Lacouture, Shenhong Wu, Caroline Robert, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Retrospective analysis of the safety and efficacy of interleukin-2 after prior VEGF-targeted therapy in patients with advanced renal cell carcinomaDaniel C Cho, Igor Puzanov, Meredith M Regan, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinomaDavid E Avigan, Baldev Vasir, Daniel J George, et al.Science Advances|October 25, 2023
Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic miceChao Liu, Srilakshmi Yalavarthi, Ajay Tambralli, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanomaRichard W Joseph, Ryan J Sullivan, Robyn Harrell, et al.Pageof 56